Portfolio company
Mylan
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Mylan manufactures generic and specialty pharmaceuticals for global patients, following its acquisition of Meda and subsequent merger to form Viatris.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Meda
This pharmaceutical company produces speciality and consumer healthcare medicines for patients and medical providers worldwide.
Actelion
This company develops and manufactures pharmaceutical drugs to treat orphan diseases such as pulmonary arterial hypertension for patients and healthcare providers globally.
Alvogen
This company develops and manufactures generic, branded and injectable pharmaceutical products for the global healthcare market.
Alvion
This pharmaceutical company develops and manufactures generic and value-added medicines for global healthcare partners and patients.
Eon Laboratories
This pharmaceutical manufacturer develops and markets a range of generic prescription drugs for healthcare providers and patients.
ViiV Healthcare
This company develops and provides pharmaceutical medicines for the treatment and prevention of HIV for patients and healthcare professionals.
Middlebrook
Middlebrook Pharmaceuticals manufactures anti-infective drugs for patients with medical needs such as tonsillitis and pharyngitis.
V-Ensure
This company develops and manufactures complex generic pharmaceutical formulations, including solid and liquid oral dosages, for global healthcare providers and pharmaceutical firms.
